Skip to Content

APO M250 (Mycophenolate mofetil 250 mg)

Pill imprint APO M250 has been identified as Mycophenolate mofetil 250 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; dermatomyositis; autoimmune hepatitis; organ transplant, rejection prophylaxis; cogan's syndrome (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil 250 mg APO M250
Mycophenolate mofetil 250 mg APO M250 Front
Mycophenolate mofetil 250 mg APO M250 Back
Mycophenolate mofetil 250 mg APO M250
Mycophenolate mofetil
Imprint:
APO M250
Strength:
250 mg
Color:
Blue & Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-2968
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
gelatin
sodium lauryl sulfate
ferric oxide red
titanium dioxide
indigotindisulfonate sodium
shellac
alcohol
isopropyl alcohol
butyl alcohol
propylene glycol
ammonia
ferrosoferric oxide
potassium hydroxide
water
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0587 Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide